Skip to content
TREAT TB logo
Search icon Menu icon
Close menu
  • Our Work
    • STREAM Trial
      • Trial Overview
      • Trial Sites
      • Community Engagement
      • Results
    • Operational Research
    • Capacity Building
    • Technical Assistance
  • About
    • Partners and Donors
  • News
  • Resources
  • Publications
Close search
  • Resources
  • Presentations Resources

Presentations Resources

Examining the efficacy of the short MDR-TB regimen: alternative analyses from the STREAM trial

Published: November 5, 2019

QT prolongation and its evolution over time in STREAM 1

Published: November 2, 2019

TB medicine costs for rifampin-resistant tuberculosis treated with a shorter regimen

Published: November 2, 2019

Predictive factors of prolonged QT in STREAM trial

Published: November 2, 2019

Efficacy of Genotype MTBDRsl assay to exclude Fluoroquinolone and Second Line Injectable Drug Resistant Mycobacterium tuberculosis in a Multidrug Resistant Tuberculosis Clinical Trial

Published: November 2, 2019

Health workers’ perception of the shorter regimen in MDR-TB treatment: Qualitative evidence from Ethiopia

Published: November 2, 2019

Experience using tablet technology for detection and monitoring of hearing loss among patients with MDR-TB in the STREAM clinical trial

Published: November 1, 2019

Evaluation of Dissemination of Preliminary Results from STREAM Stage 1

Published: November 1, 2019

Posts navigation

Page 1 Page 2 Next page

The information provided on this website is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.


TREAT TB
100 Broadway, 4th floor
New York, NY 10005
treattb@vitalstrategies.org
+1.212.500.5720
Copyright © TREAT TB
This site uses cookies to help improve your online experience. Read The Union’s Privacy and Cookies Policy, which also explains how to change your preferences. By using this site you agree to the use of cookies.OKThe Union’s Privacy and Cookies Policy